Dr. Arijit Chakravarty, MD

Dr. Chakravarty practices at Baptist Memorial Hospital-DeSoto in Southaven, Mississippi, part of Baptist Memorial Health Care.

Dr. Chakravarty's NPI, 1386778199, was assigned on March 15, 2007. Dr. Chakravarty graduated from Rutgers New Jersey Medical School in 1999. Dr. Chakravarty's West Virginia license number on file is 33544.

Dr. Chakravarty's primary practice is Baptist Memorial Hospital-DeSoto, at 7601 Southcrest Parkway, Southaven, MS 38671 in De Soto County. The practice phone is (662) 772-4000.

Dr. Chakravarty's primary practice is Baptist Memorial Hospital-DeSoto in Southaven, Mississippi, part of Baptist Memorial Health Care. Dr. Chakravarty is also affiliated with Methodist University Hospital. The medical group on file is Mid-South Nephrology. Dmand AI also links Dr. Chakravarty to 3 more hospitals, 2 group practices and clinics, 1 dialysis center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chakravarty practices, 8 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Chakravarty's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Chakravarty is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Chakravarty's licenses on file in 9 states: West Virginia, Arkansas, Tennessee, Mississippi, Michigan, Colorado, New Jersey, Pennsylvania and New York.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, gout, hypercalcemia and parathyroid gland disorder among the conditions Dr. Chakravarty treats.

CMS data shows 1,459 Medicare services from Dr. Chakravarty across 10 procedure codes in 2024, for 378 Medicare patients. Medicare paid $109,625 for them.

CMS counts 378 Medicare patients who saw Dr. Chakravarty in 2026. The largest group is 75 to 84, with 123 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 31% are also on Medicaid. Their average risk score is 4.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chakravarty's median patient age at 67, with 50% women.

In 2026, Dr. Chakravarty wrote 126 Medicare Part D claims for 42 patients. 87% of them were for generic drugs. CMS names the drug for 36 of them, across 3 drugs with 11 or more claims each, at $313 in total drug cost. In 2023, CMS named 154 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Chakravarty for performance year 2026, reported as part of a group. Dr. Chakravarty accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 19 papers to Dr. Chakravarty, published from 2007 to 2024. 2021 was the busiest year, with 7. The most frequent topics are COVID-19, SARS-CoV-2 and Pandemics. Dr. Chakravarty has published most often in PLoS One. Dr. Chakravarty's most frequent co-authors are Natasha S. Hochberg, MD, Ryan Nolan, MD and Michael S. Rogers, MD.

CMS Open Payments shows 176 general payments to Dr. Chakravarty from 22 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 64% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $15,828.

Dmand AI lists 2 awards for Dr. Chakravarty, most recently Inside Jersey Magazine Top Doctors in 2014.

Dr. Chakravarty graduated from Rutgers New Jersey Medical School in 1999. Dr. Chakravarty is a member of ACP, ASN and American Society Of Transplantation.

Dr. Chakravarty is in network with 12 carriers, including Aetna, Cigna and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.